Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19
Shikha Patel, Bhagawati Saxena, Priti Mehta
Heliyon (2021) Vol. 7, Iss. 2, pp. e06158-e06158
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Francesca Coperchini, Luca Chiovato, Mario Rotondi
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 107
Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
Supreeti Mahajan, Shweta Choudhary, Pravindra Kumar, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116356-116356
Open Access | Times Cited: 81
Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling
Gaetano Zizzo, Antonio Tamburello, Laura Castelnovo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
Shima Makaremi, Ali Asgarzadeh, Hamed Kianfar, et al.
Inflammation Research (2022) Vol. 71, Iss. 7-8, pp. 923-947
Open Access | Times Cited: 51
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Chiara Ripamonti, Valeria Spadotto, Pietro Pozzi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Current status and prospects of IL-6–targeting therapy
Masashi Narazaki, Tadamitsu Kishimoto
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 5, pp. 575-592
Open Access | Times Cited: 27
Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments
Shuwu Zhao, Yiming Li, Yilin Li, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 2, pp. 241-256
Open Access | Times Cited: 17
Cationic liposomes encapsulating IL-2 selectively induce apoptosis and significantly reduce the secretion of cytokines on M1-murine polarized macrophages
Carlos Adrián Vargas-Ángeles, Leonardo Trujillo-Cirilo, Edith Sierra-Mondragón, et al.
Cytokine (2025) Vol. 189, pp. 156903-156903
Open Access
Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2
Pravas Kumar Baral, Yin Jiang, Michael N.G. James
International Journal of Biological Macromolecules (2021) Vol. 186, pp. 490-500
Open Access | Times Cited: 33
Treatments for COVID-19: Lessons from 2020 and new therapeutic options
Fanny Salasc, Thomas Lahlali, Emilie Laurent, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 43-59
Open Access | Times Cited: 32
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2
Saba Rahimi Bahoosh, Yalda Shokoohinia, Mahdieh Eftekhari
DARU Journal of Pharmaceutical Sciences (2022) Vol. 30, Iss. 1, pp. 245-252
Open Access | Times Cited: 18
Sudden Sensorineural Hearing Loss Post Coronavirus Disease: A Systematic Review of Case Reports
Abishek Umashankar, Praveen Prakash, Prashanth Prabhu
Indian Journal of Otolaryngology and Head & Neck Surgery (2021) Vol. 74, Iss. S2, pp. 3028-3035
Open Access | Times Cited: 23
Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
Racheal G. Akwii, Constantinos M. Mikelis
Drugs (2021) Vol. 81, Iss. 15, pp. 1731-1749
Open Access | Times Cited: 21
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update
Md. Easin Mia, Mithu Howlader, Farzana Akter, et al.
Clinical Pathology (2024) Vol. 17
Open Access | Times Cited: 2
The IL-33/ST2 axis promotes ARDS by killing natural T cells
Lijuan Zou, Wenpei Dang, Yiming Tao, et al.
Shock (2023) Vol. 59, Iss. 6, pp. 902-911
Open Access | Times Cited: 7
Investigating how Interleukin 6 Serum Level, Blood Group Type, and Underlying Diseases are Associated in Patients Admitted to the COVID-19 Intensive Care Unit: A Retrospective Study
Zahra Abbasi, Ali Moghadaci, Leila Mohammadnahal, et al.
The Open Public Health Journal (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Soluble ligands as drug targets for treatment of inflammatory bowel disease
Xuhui Tong, Yuanyuan Zheng, Yu Li, et al.
Pharmacology & Therapeutics (2021) Vol. 226, pp. 107859-107859
Closed Access | Times Cited: 14
Micronutrient therapy and effective immune response: a promising approach for management of COVID-19
Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, et al.
Infection (2021) Vol. 49, Iss. 6, pp. 1133-1147
Open Access | Times Cited: 14
Gold single atom-based aptananozyme as an ultrasensitive and selective colorimetric probe for detection of thrombin and C-reactive protein
Gona K. Ali, Faisal K. Algethami, Khalid M. Omer
Microchimica Acta (2023) Vol. 191, Iss. 1
Closed Access | Times Cited: 5
Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense
Abualgasim Elgaili Abdalla, Jianping Xie, Kashaf Junaid, et al.
Bosnian Journal of Basic Medical Sciences (2021)
Open Access | Times Cited: 11
Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in Urine of Hospitalized Patients With Coronavirus Disease 2019
Nicolas Veyrenche, Amandine Pisoni, Ségolène Debiesse, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 5, pp. 812-821
Open Access | Times Cited: 7
An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives
Arijit Ghosh, Paritosh K. Kar, Anupam Gautam, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 6, pp. 647-675
Open Access | Times Cited: 6
Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis
Jiefeng Zhao, Jinfeng Zhu, Chao Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience
Wiktor Schmidt, Katarzyna Pawlak‐Buś, Barbara Jóźwiak, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2429-2429
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top